"Meningeal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
| Descriptor ID |
D008577
|
| MeSH Number(s) |
C04.588.614.250.580 C10.551.240.500
|
| Concept/Terms |
Meningeal Neoplasms- Meningeal Neoplasms
- Neoplasms, Meningeal
- Meningeal Neoplasm
- Neoplasm, Meningeal
- Meningeal Tumors
- Meningeal Tumor
- Tumor, Meningeal
- Tumors, Meningeal
Malignant Meningeal Neoplasms- Malignant Meningeal Neoplasms
- Malignant Meningeal Neoplasm
- Meningeal Neoplasm, Malignant
- Neoplasm, Malignant Meningeal
- Neoplasms, Malignant Meningeal
- Meningeal Neoplasms, Malignant
- Meningeal Cancer
- Cancer, Meningeal
- Cancers, Meningeal
- Meningeal Cancers
Intracranial Meningeal Neoplasms- Intracranial Meningeal Neoplasms
- Intracranial Meningeal Neoplasm
- Meningeal Neoplasm, Intracranial
- Neoplasm, Intracranial Meningeal
- Neoplasms, Intracranial Meningeal
- Meningeal Neoplasms, Intracranial
Leptomeningeal Neoplasms- Leptomeningeal Neoplasms
- Leptomeningeal Neoplasm
- Neoplasm, Leptomeningeal
- Neoplasms, Leptomeningeal
Spinal Meningeal Neoplasms- Spinal Meningeal Neoplasms
- Meningeal Neoplasm, Spinal
- Meningeal Neoplasms, Spinal
- Neoplasm, Spinal Meningeal
- Neoplasms, Spinal Meningeal
- Spinal Meningeal Neoplasm
Benign Meningeal Neoplasms- Benign Meningeal Neoplasms
- Benign Meningeal Neoplasm
- Meningeal Neoplasm, Benign
- Neoplasm, Benign Meningeal
- Neoplasms, Benign Meningeal
- Meningeal Neoplasms, Benign
|
Below are MeSH descriptors whose meaning is more general than "Meningeal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Meningeal Neoplasms".
This graph shows the total number of publications written about "Meningeal Neoplasms" by people in this website by year, and whether "Meningeal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 0 | 1 | 1 |
| 2002 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 0 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 1 | 4 |
| 2020 | 2 | 0 | 2 |
| 2021 | 6 | 0 | 6 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 4 | 2 | 6 |
| 2025 | 4 | 0 | 4 |
| 2026 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Meningeal Neoplasms" by people in Profiles.
-
Variation in meningioma recurrence risk estimates across observational cohorts: the influence of calendar time, WHO classifications, geographical settings, and healthcare systems. J Neurooncol. 2026 Aug 28; 179(2).
-
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma. J Clin Oncol. 2026 Aug 10; 44(23):2169-2175.
-
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients. Acta Neurochir (Wien). 2026 04 06; 168(1).
-
Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients. J Neurooncol. 2026 Feb 09; 176(3):201.
-
Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases. Breast. 2026 Feb; 85:104674.
-
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases. J Thorac Oncol. 2026 03; 21(3):103505.
-
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid. Eur J Cancer. 2025 Oct 16; 229:115783.
-
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104. J Neurooncol. 2025 Jul; 173(3):751-757.
-
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2024 12; 8:e2400373.
-
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.